Research finds support for acceptance of Vasalgel
Almost half of men participating in a survey said they would use Vasalgel if it were available. In the study recently published in Cogent Medicine,
Join our email list and pick the topics that interest you.
Click here to see news about only Human Health topics or click here to see news about only Pet Health.
Almost half of men participating in a survey said they would use Vasalgel if it were available. In the study recently published in Cogent Medicine,
Vasalgel and other new male contraceptives were highlighted in an article in The Telegraph. Written by Aaron Hamlin, the executive director of the Male Contraception
Parsemus Foundation Founder and Trustee Elaine Lissner recently selected Linda Brent as the Executive Director of the organization. Linda consulted with the organization for several
Once Vasalgel male contraceptive is available, how will the men who have it know that it’s still in place? Of course the most important thing
A key goal for Vasalgel is that it would not only be an effective long-acting male contraceptive, but also be reversible: a Vasalgel user who
THANK YOU to all the Vasalgel supporters who stepped up to meet the $5,000 one-day challenge last week. One of Vasalgel’s biggest supporters — a
We’re making the clinical trial batch of Vasalgel this month! And we need your help! Parsemus Foundation is a small organization that’s determined to provide
If you’ve been following Vasalgel for some time, you already know that this new, long-acting contraceptive worked well in rabbits. But now it’s official! The
A key goal for the first Vasalgel studies, in addition to demonstrating the contraceptive’s safety and effectiveness, was to establish its reversibility. Vasalgel was reversible
With a year of animal efficacy studies done on Vasalgel male contraceptive, we’ve demonstrated its feasibility — and it’s time to build momentum! But it
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: